Kyle Mikson CFA
Stock Analyst at Canaccord Genuity
(4.69)
# 799
Out of 4,703 analysts
458
Total ratings
46.4%
Success rate
16%
Average return
Main Sectors:
Stocks Rated by Kyle Mikson CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CDNA CareDx | Initiated Coverage: Buy | $65 | $50.88 | +27.75% | 1 | Sep 2, 2026 | |
| BLLN BillionToOne | Initiated Coverage: Buy | $120 | $99.39 | +20.74% | 1 | Sep 2, 2026 | |
| TEM Tempus AI | Maintained: Buy | $80 | $64.62 | +23.80% | 12 | Sep 1, 2026 | |
| PACB Pacific Biosciences of California | Reiterated: Buy | $3 | $1.35 | +122.22% | 35 | Aug 17, 2026 | |
| QTRX Quanterix | Reiterated: Hold | $4 → $3 | $2.69 | +11.52% | 32 | Aug 17, 2026 | |
| SEER Seer, Inc. | Reiterated: Buy | $4 | $1.95 | +105.13% | 4 | Aug 11, 2026 | |
| TXG 10x Genomics | Reiterated: Buy | $50 → $60 | $62.65 | -4.23% | 31 | Aug 10, 2026 | |
| BDSX Biodesix | Reiterated: Buy | $27 → $35 | $26.18 | +33.69% | 29 | Aug 10, 2026 | |
| NTRA Natera | Maintained: Buy | $330 → $375 | $328.18 | +14.27% | 37 | Aug 7, 2026 | |
| CAI Caris Life Sciences | Reiterated: Hold | $22 | $25.07 | -12.25% | 9 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $9 | $7.58 | +18.73% | 26 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 | $80.34 | -0.42% | 15 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 → $90 | $85.99 | +4.66% | 11 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $190 → $205 | $218.22 | -6.06% | 50 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $60 → $50 | $42.53 | +17.56% | 12 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $120 | $124.72 | -3.78% | 3 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $205 | $161.41 | +27.01% | 41 | Aug 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $32.91 | +21.54% | 27 | Aug 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $145 | $167.60 | -13.48% | 12 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 200p → 180p | 161p | +11.52% | 10 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $271 | $17.85 | +1,416.69% | 1 | Jun 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $0.9395 | +219.32% | 19 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $0.766 | +30.55% | 22 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 → $5 | $0.001 | n/a | 12 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $15 | $14.15 | n/a | 3 | Jun 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $5.28 | n/a | 1 | Mar 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $0.3496 | n/a | 1 | Mar 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $0.30 | n/a | 1 | Jan 28, 2021 |
CareDx
Sep 2, 2026
Initiated Coverage: Buy
Price Target: $65
Current: $50.88
Upside: +27.75%
BillionToOne
Sep 2, 2026
Initiated Coverage: Buy
Price Target: $120
Current: $99.39
Upside: +20.74%
Tempus AI
Sep 1, 2026
Maintained: Buy
Price Target: $80
Current: $64.62
Upside: +23.80%
Pacific Biosciences of California
Aug 17, 2026
Reiterated: Buy
Price Target: $3
Current: $1.35
Upside: +122.22%
Quanterix
Aug 17, 2026
Reiterated: Hold
Price Target: $4 → $3
Current: $2.69
Upside: +11.52%
Seer, Inc.
Aug 11, 2026
Reiterated: Buy
Price Target: $4
Current: $1.95
Upside: +105.13%
10x Genomics
Aug 10, 2026
Reiterated: Buy
Price Target: $50 → $60
Current: $62.65
Upside: -4.23%
Biodesix
Aug 10, 2026
Reiterated: Buy
Price Target: $27 → $35
Current: $26.18
Upside: +33.69%
Natera
Aug 7, 2026
Maintained: Buy
Price Target: $330 → $375
Current: $328.18
Upside: +14.27%
Caris Life Sciences
Aug 6, 2026
Reiterated: Hold
Price Target: $22
Current: $25.07
Upside: -12.25%
Aug 5, 2026
Maintained: Buy
Price Target: $8 → $9
Current: $7.58
Upside: +18.73%
Aug 5, 2026
Maintained: Buy
Price Target: $80
Current: $80.34
Upside: -0.42%
Aug 4, 2026
Reiterated: Buy
Price Target: $75 → $90
Current: $85.99
Upside: +4.66%
Aug 3, 2026
Maintained: Hold
Price Target: $190 → $205
Current: $218.22
Upside: -6.06%
Aug 3, 2026
Maintained: Hold
Price Target: $60 → $50
Current: $42.53
Upside: +17.56%
Aug 3, 2026
Maintained: Buy
Price Target: $120
Current: $124.72
Upside: -3.78%
Aug 2, 2026
Maintained: Buy
Price Target: $205
Current: $161.41
Upside: +27.01%
Aug 2, 2026
Maintained: Buy
Price Target: $40
Current: $32.91
Upside: +21.54%
Jul 28, 2026
Maintained: Hold
Price Target: $145
Current: $167.60
Upside: -13.48%
Jul 14, 2026
Reiterated: Buy
Price Target: 200p → 180p
Current: 161p
Upside: +11.52%
Jun 18, 2026
Reiterated: Buy
Price Target: $271
Current: $17.85
Upside: +1,416.69%
May 15, 2026
Reiterated: Buy
Price Target: $3
Current: $0.9395
Upside: +219.32%
May 8, 2026
Reiterated: Hold
Price Target: $1
Current: $0.766
Upside: +30.55%
Jul 29, 2024
Maintained: Hold
Price Target: $3 → $5
Current: $0.001
Upside: n/a
Jun 1, 2021
Maintained: Buy
Price Target: $13 → $15
Current: $14.15
Upside: n/a
Mar 29, 2021
Initiated Coverage: Buy
Price Target: $8
Current: $5.28
Upside: n/a
Mar 9, 2021
Initiated Coverage: Buy
Price Target: $8
Current: $0.3496
Upside: n/a
Jan 28, 2021
Initiated Coverage: Buy
Price Target: $10
Current: $0.30
Upside: n/a